Kelley Kenneth J Insider Trades

Insider Trading History

Track insider trading activity for Kelley Kenneth J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $12.9M 179,833 shares
Last Trade
Apr 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$225k 5,000 shares
$45.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $13.3M 185,333 shares
Last Trade
Mar 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$227k 5,000 shares
$45.34
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $13.6M 190,079 shares
Last Trade
Feb 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$241k 5,000 shares
$48.12
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $14M 195,123 shares
Last Trade
Jan 04, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$215k 5,000 shares
$42.91
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $14.3M 199,833 shares
Last Trade
Dec 07, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.44M 35,086 shares
$41.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $16.8M 234,919 shares
Last Trade
Dec 02, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.3M 31,792 shares
$41.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $19.1M 266,711 shares
Last Trade
Nov 27, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$413k 10,000 shares
$41.25
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $19.8M 276,711 shares
Last Trade
Nov 25, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$401k 9,671 shares
$41.50
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $20.5M 286,382 shares
Last Trade
Apr 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 8,829 shares
$22.66
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $19.9M 277,553 shares
Last Trade
Mar 19, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$250k 17,543 shares
$14.24
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $16.1M 224,924 shares
Last Trade
May 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 12,173 shares
$16.43
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $15.2M 212,751 shares
Last Trade
May 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 10,363 shares
$19.30
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $14.5M 202,388 shares
Last Trade
May 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 14,135 shares
$14.15
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $13.5M 188,253 shares
Last Trade
May 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 20,202 shares
$9.90
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $14.9M 208,051 shares
Last Trade
Aug 28, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 10,000 shares
$18.41
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $0 0 shares
Last Trade
Aug 28, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 10,000 shares
$18.41
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $14.2M 198,051 shares
Last Trade
Jun 18, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$420k 20,000 shares
$21.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $0 0 shares
Last Trade
Jun 05, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200k 10,000 shares
$19.97
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $15.6M 218,051 shares
Last Trade
Jun 05, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200k 10,000 shares
$19.97
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $14.9M 208,051 shares
Last Trade
May 06, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 13,175 shares
$15.18
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up